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CHAPTER I 
 
INTRODUCTION 
 
Control of action in schizophrenia 
Executive function refers to the diverse cognitive abilities, largely subserved by 
frontal cortex, involved in the control of thought and action.  Patients with schizophrenia 
have consistently been shown to have profound executive dysfunction (for review see, 
Barch, 2005).  Although cognitive functioning is one of the most reliable predictors of 
functional outcome (Green, 1996), typical neuroleptic drugs used to treat schizophrenia 
do little to improve these deficits. As a group, atypical antipsychotics appear to be an 
improvement over typical neuroleptics, and there is evidence that different atypical 
antipsychotic drugs have different effects on specific cognitive functions (Meltzer & 
McGurk, 1999).  This underscores the importance of investigating the specificity of 
executive dysfunction in schizophrenia in order to guide targeted interventions.  
Moreover, executive dysfunction appears to be present in both early in the course of 
illness (e.g. Chan, Chen, & Law, 2006) and in first-degree relatives (e.g. Park, Holzman, 
& Goldman-Rakic, 1995), indicating that executive dysfunction is a possible 
endophenotype, a trait marker of genetic liability, of the disease. 
Two executive functions critically involved in the control of action are response 
inhibition and performance monitoring (Kok, et al., 2006).  Response inhibition is 
defined as the ability to deliberately inhibit actions (Rabbitt, 1997). Patients with 
schizophrenia perform poorly on tasks that rely on response inhibition, such as the 
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Stroop task (eg., Brazo et al., 2002; Donohoe, Corvin, & Robertson, 2006) and 
antisaccade tasks (eg., Curtis, Calkins, & Iacono, 2001; Manoach et al., 2002).  Results 
using the Go/No-Go task, in which subjects are required to respond to one stimulus 
(Go) but not to the other (NoGo), are mixed.  Some studies have found that patients 
make more false-alarm errors to NoGo stimuli (Kiehl, Smith, Hare, & Liddle, 2000; 
Weisbrod, Kiefer, Marzinzik, & Spitzer, 2000), whereas others have not (Rubia et al., 
2001).  One study found that patients made fewer false-alarm errors than controls, likely 
due to the patients establishing less of a prepotent stimulus-response mapping to the 
Go stimuli (Ford et al., 2004).   Correlations of task performance with symptoms have 
suggested an association with negative (Donohoe, Corvin, & Robertson, 2006; Mahurin, 
Velligan, & Miller, 1998) and disorganized symptoms (Brazo et al., 2002; Leeson, 
Simpson, McKenna, & Laws, 2005).  Although the data are mixed (Brownstein et al., 
2003), deficits in response inhibition have also been found in unaffected relatives of 
patients (Curtis, Calkins, & Iacono, 2001; Kumari, Ettinger, Crawford, Zachariah, & 
Sharma, 2005).  
Performance monitoring involves the ability to evaluate actions and use feedback 
signaling success or failure to guide future performance.  Performance monitoring is 
commonly indexed by error detection on a cognitive task and subsequent response time 
(RT) adjustments.  Error detection is thought to be accompanied by ACC activation; this 
region is purported to be the generator of the error-related negativity (ERN), an event-
related potential that follows 80-180 ms following an error (Dehaene, Posner, & Tucker, 
1994; Gehring, Goss, Coles, Meyer, & Donchin, 1993; Van Veen & Carter, 2002).   
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Frith (1992) has posited a theory that positive symptoms are the result of a failure to 
effectively self-monitor, such that internally generated thoughts and actions are 
attributed externally, and there has been empirical support for this claim including 
impaired error correction (Frith & Done, 1989; Malenka, Angel, Hampton, & Berger, 
1982) and misattribution of the source of self-generated speech (Brebion et al., 2000; 
Cahill, 1996).  However, evidence for deficits in immediate error-related performance 
adjustments, such as post-error slowing and error correction, in patients with 
schizophrenia is mixed.  Some studies have found intact post-error adjustments (Kopp 
& Rist, 1994, 1999; Laurens, Ngan, Bates, Kiehl, & Liddle, 2003; Mathalon et al., 2002; 
Polli et al., 2006).  Others have reported impairments in trial-by-trial performance 
adjustments (Carter, MacDonald, Ross, & Stenger, 2001; Malenka, Angel, Hampton, & 
Berger, 1982; Malenka, Angel, Thiemann, Weitz, & Berger, 1986; Turken, Vuilleumier, 
Mathalon, Swick, & Ford, 2003).  In contrast, patients consistently show reduced ERN 
amplitude following errors (Alain, McNeely, He, Christensen, & West, 2002; Kopp & 
Rist, 1999; Mathalon et al., 2002), and reduced ACC hemodynamic activity during error 
trials using event-related fMRI (Carter, MacDonald, Ross, & Stenger, 2001; Laurens, 
Ngan, Bates, Kiehl, & Liddle, 2003). 
The vast literature on executive function in schizophrenia gives rise to the 
question of whether deficits in multiple domains (i.e. inhibition, response monitoring, 
working memory, etc.) represent semi-independent deficits or are subsumed under a 
fundamental impairment.  Goldman-Rakic and colleagues (Goldman-Rakic, 1994; Park, 
Holzman, & Goldman-Rakic, 1995) have argued that the ability to guide behavior by 
working memory is the core deficit.  In a similar vein, Barch and colleagues have 
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suggested that the ability to represent and maintain context information is impaired in 
schizophrenia (Barch et al., 2001; Braver, Barch, & Cohen, 1999; Braver & Cohen, 
1999).  This idea is similar to the idea of goal neglect put forth by Duncan (1996), a 
failure to active a target state that is necessary to fulfill current task requirements and 
echos Frith’s (1992) theory that schizophrenia can be characterized as a “disorder of 
willed action”.   
 
Saccade countermanding paradigm 
 An important consideration in these studies of executive function in 
schizophrenia is the variety of instruments used; measurements of inhibition and 
performance monitoring might be confounded by the involvement of other cognitive 
processes.  The stop signal, or countermanding, task has been used to investigate the 
ability to control initiation of a response (Lappin & Eriksen, 1966).  In the oculomotor 
version of the task, a target appears in the periphery, and the subject is instructed to 
make a saccade to that target (no-stop signal trial) unless a subsequent stop signal 
appears (signal trial); in which case, the subject is instructed to withhold the prepotent 
response. Signal trials in which the subject is able to withhold the saccade are labeled 
cancelled, and signal trials in which the subject is not able to withhold the saccade to 
the target are labeled noncancelled.  Subjects become less able to cancel a saccade as 
the stop signal delay (SSD), latency between the initial appearance of the peripheral 
target and the stop signal, increases.  The inhibition function plots the proportion of 
noncancelled trials at each stop signal delay.  Flatter inhibition slopes could indicate 
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poor capability for response inhibition or less sensitivity to the stop signal due to 
impairments in stimulus-response mappings. 
 
 
Figure 1.  Race-model estimation of SSRT.  A distribution of no-stop signal RTs is 
shown beneath the curve. SSD is the delay between target presentation and stop 
signal. The stop signal divides the no-stop signal RT distribution into two probabilities: a 
left part consisting of responses fast enough to escape inhibition (P respond) and a right 
part corresponding to P inhibit. 
 
 
 
Performance in the stop signal task can be accounted for by a model based on a 
race between STOP and GO processes with independent stochastic finishing times 
(Figure 1; Logan & Cowan, 1984).  Depending on whether the GO or STOP process 
‘wins’, the response is executed or inhibited, respectively.  This model provides an 
estimate of the time needed to respond to the stop signal and cancel the movement, the 
stop signal reaction time (SSRT), calculated using the distribution of RTs on no-stop 
signal trials and the probability of responding given a stop signal occurred.  It has an 
advantage over other measures of inhibition in that, along with measuring the ability to 
inhibit a pre-potent response, it provides a measure of the time to cancel a planned 
action that is not confounded with group differences in mean and variability of GO trial 
RT. 
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 Specific performance adjustments according to trial history have also been 
reported in this task.  RTs on no-stop signal trials are significantly longer when they 
were preceded by correctly cancelled stop signal trials but less so following incorrect, 
noncancelled stop signal trials (Cabel, Armstrong, Reingold, & Munoz, 2000; Emeric et 
al., 2007; Kornylo, Dill, Saenz, & Krauzlis, 2003).  In other words, no significant post-
error slowing was observed.  Emeric et al. (2007) suggest that the absence of post-error 
slowing may be due to high incidence and low cost of errors in this task.  They also 
suggest that the increase in RT following cancelled trials may be due to compensatory 
adjustments in control due to response conflict between the mutually incompatible 
STOP process, identified with the activity of fixation neurons in the frontal eye fields 
(FEF), and the GO process, identified with presaccadic movement neurons in the FEF 
and superior colliculus (Schall & Boucher, 2007).  The FEF is a brain region located in 
premotor cortex and implicated in the initiation of goal-directed saccades (Paus, 1996).  
This interpretation that trial-by-trial RT adjustments are due to conflict is supported by 
the discovery that single neurons in the supplementary eye field (SEF) signal conflict 
(Stuphorn, Taylor, & Schall, 2000), and that subthreshold microstimulation of SEF 
improves performance on the countermanding task by delaying saccade initiation 
(Stuphorn & Schall, 2006).  Thus, there is an identifiable neural mechanism by which 
conflict is detected and subsequent RT adjustments are made.  
 Only a few studies of response inhibition in schizophrenia using the stop signal 
task have been conducted, and results have been mixed.  Badcock et al. (2002) found 
equal SSRT but decreased slope of the inhibition function; as mentioned above, this 
could arise from poorer capability for response inhibition or less sensitivity to the stop 
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signal.  They interpreted this finding as a deficit in control and planning of stop 
processes, rather than slowing of the stop processes.  However, another group 
(Bellgrove et al., 2006) found increased SSRT in an early-onset schizophrenia sample, 
but only for left hand responses.  Both of these studies used manual responses.  Since 
slowed manual response time is a very consistent finding in patients (see Nuechterlein, 
1977), it is difficult to distinguish whether inhibitory difficulties are occurring at a more 
executive or peripheral level.  
There are a few major benefits to using an oculomotor versus manual version of the 
stop signal task in schizophrenia.  Reuter and Kathmann (2004) argue for the 
advantage of using saccade tasks in studying cognitive deficits since they seem to show 
greater sensitivity in detecting subtle neuropsychological impairments (Broerse, 
Holthausen, van den Bosch, & den Boer, 2001).  They also contend that because of the 
simple nature of saccade tasks, they have the potential to be used in analyzing specific 
components of executive dysfunction.  Additionally, slowed RT for manual but not 
saccadic eye movements in schizophrenia is a consistent finding in the literature (Gale 
& Holzman, 2000; Nuechterlein, 1977), implying that the circuitry underlying basic 
visually guided saccades is intact.  Using saccade tasks potentially reduces 
confounding effects that are not due to additional cognitive demands, like low-level 
motor function differences.  Importantly, the neural circuitry of the oculomotor system is 
very well mapped, and using an oculomotor version of the task allows more direct 
applications of spatially and temporally precise intracranial recordings in non-human 
primates in order to build translational links to models of schizophrenia. 
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To summarize, the oculomotor stop signal task provides a precise measure of the 
inhibitory process by permitting both a measurement of the estimated time needed to 
inhibit a response, as well as a measurement of control over these inhibitory processes.  
Moreover, we can derive measures of response monitoring by examining RT 
adjustments based on performance in the prior trial.  In the present study, we 
hypothesize that: 1) the speed of inhibitory processes is intact in patients, but the 
inhibitory response is triggered less often, suggesting a failure of goal updating; 2)  
healthy subjects will show significant elevation of response time following stop signal 
trials versus no-stop signal trials, particularly following cancelled trials, and 
schizophrenic subjects will exhibit idiosyncratic variability in the magnitude of these 
adjustments; 3) indices of response monitoring will be associated with decreased 
positive symptomology such that patients scoring lower on positive symptoms will 
exhibit increased post-error and post-cancelled slowing 
 
 
  9 
CHAPTER II 
 
METHODS 
 
Participants 
Nine schizophrenia patients and six healthy controls completed the experiment.  
Notably, one patient was excluded because he could not inhibit his responses at any of 
the SSDs.  Patients that met Diagnostic and Statistical Manual of Mental Disorders IV 
(DSM-IV) criteria were recruited from an outpatient treatment facility in Nashville,TN, 
and diagnoses were confirmed from the Structured Clinical Interview for DSM-IV (SCID; 
First, Spitzer, Gibbon, & Williams, 1995).  All patients were on a stable dose of atypical 
antipsychotic medication at the time of the experiment, on a mean chlorpromazine dose 
equivalent of 328 mg.  Clinical symptoms were assessed with the Brief Psychiatric 
Rating Scale (BPRS; Overall & Gorham, 1962), the Scale for Assessment of Positive 
Symptom (SAPS; Andreasen & Olsen, 1982), and the Scale for Assessment of 
Negative Symptom (SANS; Andreasen & Olsen, 1982).  Control participants with no 
history of mental illness, confirmed with the SCID, were recruited from the community.  
Exclusion criteria were as follows: a history of substance dependence, neurological 
trauma or mental retardation.  Patients and controls were matched for age, sex, and full 
scale IQ on the Wechsler Abbreviated Scale of Intelligence (See Table 1 for 
demographic data). 
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Table 1.  Means, standard deviations and group comparisons of demographic data and 
symptom rating scores.  The Phi value is the result of a Fisher’s Exact Test. 
 
 Healthy 
Controls 
(n=6) 
Schizophrenia 
Patients (n=8) 
t p 
Age 35.6±3.5 37.3±3.1 .33 .74 
Sex 4F/2M 3F/5M Phi=.06 .59 
WASI FSIQ 103±7 99±6 .51 .62 
SAPS (min: 0, max: 175) 15.8±7.1 
SANS (min: 0, max: 125) 28.8±6.7 
BPRS (min: 0, max: 144) 13.4±4.0 
Mean Duration of illness 
(yrs) 
14.7 years 
Mean CPZ dosage (mg) 328  
 
 
 
Countermanding task 
 
Apparatus and Stimuli 
Eye position was monitored through pupil tracking using the EyeLink II eye tracker 
(SR Research, Canada) at a sampling rate of 250 Hz with average gaze position error 
<0.5°, noise limited to <0.01° RMS. Saccades were detected on-line using a velocity 
criterion (35°/sec).  Subjects were seated 57 cm from the computer monitor that 
delivered the visual stimuli, with their head in a chinrest. The fixation and targets 
subtended 1.0° and were light gray squares on a darker gray background. 
  
Saccadic countermanding paradigm 
Subjects performed the saccadic version of the countermanding task (Figure 2; 
Hanes & Carpenter, 1999; Hanes & Schall, 1995; Logan & Irwin, 2000).  Seventy 
percent of the trials were no-stop signal trials. These required the subject to maintain 
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central gaze on the fixation spot until it disappeared (after a uniformly random delay of 
200-600 msec) and an eccentric target appeared at one of 2 pseudo-randomly selected 
locations equidistant (8.5°) from the central fixation spot.  Subjects were instructed to 
shift gaze as quickly as possible to the appearance of the target. The other 30% of trials 
were stop signal trials. On these trials, the fixation spot re-illuminated after a delay 
(SSD), cuing subjects that the response they were to make needs to be inhibited. Stop 
signal trials were labeled cancelled or noncancelled based on whether the planned 
saccade was inhibited or not inhibited, respectively.  
Figure 2. The saccade countermanding task.  Dotted circles represent current gaze 
position. 
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A 1-up/1-down staircase procedure was used to determine the SSD on each stop 
signal trial.  The delay was adjusted in increments of 50 ms based on performance in 
the prior stop signal trial.  If the participant failed to cancel a saccade in a given trial, the 
SSD was reduced by 50 ms on the next stop signal trial.  Likewise, if the participant 
successfully cancelled a saccade, the SSD was increased by 50 ms on the next stop 
signal trial.  This procedure was used to ensure that approximately half of the stop 
signal trials were successfully inhibited.   
Saccade initiation and termination were defined as the beginning and end of 
monotonic changes in eye position before and after the high velocity gaze shift. Trials 
during which the subject was fixating on the initial central target, the saccade was 
initiated only after presentation of the peripheral target, and the saccade terminated on 
the peripheral target will be classified as valid trials. For each valid trial, response time 
is the interval from target presentation to saccade initiation. The mean response time for 
each subject is the mean of session means. 
Behavioral performance was evaluated through measurements of saccadic RTs on 
no-stop signal and noncancelled trials, and the probability of not canceling the eye 
movement as a function of SSD (the inhibition function).  A linear regression will be fit to 
the inhibition function, and the slope was calculated.  
As mentioned previously, performance in the stop signal task can be accounted for 
through a race model (Logan & Cowan, 1984). This model provides an estimate of the 
time needed to respond to the stop signal and cancel the movement, the stop signal 
reaction time (SSRT). With the integration method, the finish time of the STOP process 
is assumed to be constant. Although surely not so, violations of this assumption have 
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little effect on the validity of this estimate of SSRT (Band, van der Molen, & Logan, 
2003; Logan, Cowan, & Davis, 1984).  For each stop signal delay, SSRT is defined as 
the RT at which the integral of the no-stop signal RT distribution equals the proportion of 
noncancelled trials at that stop signal delay minus the stop signal delay. With the 
difference method, the finish time of the STOP process is assumed to be a random 
variable. The probability of responding given a stop signal at a given delay is described 
by the inhibition function. The difference method treats the inhibition function as a 
cumulative distribution. Mathematical analysis shows that the mean of this distribution 
equals the mean of the finish time for the GO process minus SSRT. Consequently, 
mean SSRT can be calculated by subtracting the mean of the inhibition function from 
the mean RT on no-stop signal trials. Difference in the values calculated by the two 
methods is typically small, so an overall SSRT estimate was taken as the average of the 
SSRT using both methods. 
To examine behavioral indices of performance monitoring, saccade RTs on no-stop 
signal trials were sorted based on performance history and examined as a function of 
whether the preceding stop signal trial was cancelled or noncancelled or was a no-stop 
signal trial.  Post-cancelled slowing was defined as the difference between mean RT of 
no-stop signal trials preceded by a cancelled trial and mean RT of no-stop signal trials 
preceded by a no-stop-signal trial.  Post-error slowing was defined as the difference 
between the mean RT of no-stop signal trials preceded by a noncancelled trial and the 
mean RT of no-stop signal trials preceded by a no-stop-signal trial  
To examine the relationship between symptomatology and measures of response 
inhibition and performance monitoring, Pearson product-moment correlations will be 
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calculated between measures of task performance and performance monitoring, 
outlined above, and positive and negative symptoms derived from the BPRS, SANS, 
and SAPS. 
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CHAPTER III 
 
RESULTS 
 
No-stop signal and noncancelled RTs 
 A repeated measures ANOVA was conducted on saccadic RTs with trial type 
(no-stop signal, noncancelled) entered as a within-subject factor and group entered as a 
between subjects factor (Figure 3).  There was a main effect of trial type (F(1,12)=41.7, 
p<.0001) with no-stop signal RTs (251±40 ms) being slower than noncancelled RTs  
(206±36 ms).  There was also a nonsignificant trend for patients to be slower than 
healthy controls (patients: 243±44 ms, healthy controls: 210±36 ms; F(1,12)=3.7, 
p=.08), but no group by trial type interaction (F(1,12)=.0004, p=.98).   
Figure 3.  Bar graph of no-stop signal and noncancelled RT in milliseconds for 
schizophrenia patients and controls with standard error bars. 
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Stop signal reaction time 
 
 An independent t-test was conducted to evaluate group differences in SSRT, and 
no significant difference was found (Figure 4; controls: 132±39, patients: 135±52; 
t(12)=.09, p=.93).  Thus, schizophrenia patients in this sample did not need more time 
to stop a planned movement. 
Figure 4.  Bar graph of stop signal reaction time in milliseconds for schizophrenia 
patients and healthy controls with standard error bars.   
 
 
Slope of inhibition function 
 An independent t-test was conducted to evaluate group differences in the linear 
slope of the inhibition function.  Patients tended, non-significantly, to have a shallower 
slope than healthy controls (Figure 5; patients: 1.7±.90, controls: 2.9±1.3; t(12)=2.07, 
p=.06).  Since a flatter inhibition function could result from either variability in the GO or 
STOP process (Logan, 1994), within-subject variability in no-stop signal RTs was 
compared across groups.  Patients and controls did not differ in the amount of variability 
(t(12)=1.3, p=.21). 
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Figure 5.  Bar graph with standard error bars of the mean linear slope of the inhibition 
function for schizophrenia patients and healthy controls.   
 
 
Response monitoring 
 A repeated measures ANOVA was conducted on no-stop signal RTs with 
previous trial type (no-stop signal, noncancelled, cancelled) entered as a within subjects 
factor and group entered as a between subjects factor (Figure 6).  There was a 
significant main effect of previous trial (F(2,24)=43.5, p<.0001).  Pairwise comparisons 
revealed a significant difference in no-stop signal RTs between all of the previous trial 
types, with Tukey corrections for multiple comparisons (previous no-stop signal trial: 
234±38 ms, previous cancelled trial: 323±68, previous noncancelled trial: 281±48).  
There was also a main effect of group (F(1,12)=4.7, p=.05), such that patients (301±64 
ms) were slower than healthy controls (251±52 ms).  Three planned contrasts were 
conducted to examine group differences in no-stop signal RTs preceded by each of the 
trial types.  Patients were significantly slower than healthy controls on no-stop signal 
trials preceded by both cancelled (patients: 354±60 ms, controls: 281±57; t(12)=2.4, 
p=.04) and noncancelled (patients: 302±40 ms, controls: 253±45; t(12)=2.2, p=.05) stop 
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signal trials, but these differences failed to meet the Bonferroni-corrected pairwise alpha 
level (α=.017).   However, there was no group difference in RTs preceded by no-stop 
signal trials (patients: 245±35 ms, controls: 220±39 m; t(12)=1.3, p=.23).  
 
Figure 6.  Bar graph with standard error bars of mean no-stop signal RT in milliseconds 
as a function of prior trial for schizophrenia patients and healthy controls. 
 
 
Symptom correlations 
 There was a significant inverse correlation between SAPS score and amount of 
post-error slowing in patients with schizophrenia (r=-.76, z=2.2, p=.03).  Greater positive 
symptom severity was associated with less slowing following an erroneously 
noncancelled stop signal trial (Figure 7).  This correlation was not due to patients high 
on positive symptoms showing reduced post-error slowing compared to healthy 
controls.  Rather, patients low on positive symptoms showed elevated post-error 
slowing compared to controls.   There were no other significant correlations between 
symptom severity and measures of response inhibition and response monitoring.  
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Figure 7.  Linear regression of positive symptom severity on post-error slowing.  Dotted 
line represents the mean post-error slowing for healthy controls (SAPS: Scale for 
Assessment of Positive Symptoms).    
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CHAPTER IV 
 
DISCUSSION 
 
Conformity to race model 
Since this is the first study to examine performance of patients with 
schizophrenia on an oculomotor version of the stop signal task, it is important to note 
that all patients except one were able to comply with task instructions and tolerate the 
testing procedure.  Notably, two important criteria for applying the race model to this 
data were fulfilled.  First, their inhibition functions are generally increasing (i.e. as SSD 
increases, the proportion of noncancelled trials increases).  Second, the mean RT for 
no-stop signal trials is greater than the mean RT for noncancelled stop signal trials, 
which follows from the race model assumption that the RT distribution on noncancelled 
trials amounts to the portion of the no-stop signal RT distribution that are less than the 
SSD plus the SSRT.  
 
No-stop signal RT 
Although patients with schizophrenia tended non-significantly to be slower on no-
stop signal trials than healthy controls, this effect was only present for no-stop signal 
trials preceded by either cancelled or noncancelled stop signal trials; for no-stop signal 
trials preceded by no-stop signal trials, there was no group difference in RT.  This is 
consistent with several other reports of normal latency of visually guided saccades in 
schizophrenia (Gale & Holzman, 2000; Nuechterlein, 1977).   
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Response Inhibition 
 In this sample, patients with schizophrenia do not show differences in the time 
needed to cancel a planned movement, evidenced by equal stop signal reaction time. 
Once the STOP process is initiated, it does not take any longer to complete than in 
healthy controls.  However, patients tended to show a deficit in triggering the STOP 
processes, as evidenced by a reduced slope of the inhibition function, which is not 
accounted for by increased variability in no-stop signal reaction times (i.e. variability in 
the GO process).  This is consistent with an earlier report of equal SSRT but reduced 
slope of the inhibition function (Badcock, Michie, Johnson, & Combrinck, 2002) using a 
manual version of the stop signal task.   
The data also indicate that patients have a weaker stimulus-response mapping to 
the stop signal and a reduced sensitivity to the cue to inhibit, supporting the notion of a 
general impairment in using working memory to maintain representations of task-related 
goals underlying response inhibition deficits in schizophrenia.  Based on a literature 
review and their own findings, Kane and Engle (2003) argue that action control, 
measured using the Stroop task, is sensitive to individual differences in working memory 
capacity and that interference of a prepotent response on an trial requiring inhibition in 
the context of a task with many trials that require a dominant response (e.g. the stop 
signal task) is due to a transient failure of goal maintenance in working memory.  
Further, several studies of inhibition in schizophrenia using the antisaccade task have 
argued for the relevance of working memory.  Two studies have found negative 
correlations between working memory functions and proportion of reflexive saccades in 
  22 
an antisaccade task (Gooding & Tallent, 2001; Nieman et al., 2000), and Hutton et al., 
(2002) found that patients with schizophrenia showed spared inhibition if the working 
memory demand of the task was low, and inhibition deficits that increased with the 
working memory demand.  
 
Response Monitoring 
 We found a pattern of RT adjustments based on the immediately preceding trial 
similar to previous studies (Cabel, Armstrong, Reingold, & Munoz, 2000; Emeric et al., 
2007; Kornylo, Dill, Saenz, & Krauzlis, 2003), with significant RT elevation of no-stop 
signal trials  preceded by both noncancelled and cancelled stop signal trials compared 
to those preceded by a no-stop signal trial and significant elevation of RT for no-stop 
signal trials preceded by successfully cancelled versus noncancelled trials.  
Interestingly, patients showed equal no-stop signal RTs for trials that were preceded by 
a no-stop signal trial, but they showed greater no-stop signal RTs compared to controls 
for trials preceded by either a noncancelled or cancelled stop signal trial, although this 
finding failed to meet correction for multiple comparisons.  In short, patients seemed to 
show greater compensatory RT adjustments based on the presence of a stop signal in 
the prior trial.   
 There are a few theories regarding how these RT adjustments are instantiated, 
which are not necessarily incompatible.  The error-monitoring hypothesis proposes RT 
adjustments arise from a comparison between the representations of the actual 
response and the correct response (Falkenstein, Hohnsbein, Hoormann, & Blanke, 
1991; Gehring, Goss, Coles, Meyer, & Donchin, 1993).  The reinforcement-feedback 
  23 
hypotheses proposes that adjustments are elicited by feedback indicating error or 
punishment (Gehring & Willoughby, 2002; Miltner, Baum, & Coles, 1997). The conflict-
monitoring hypothesis proposes the adjustments are due to detection of coactivation of 
incompatible responses, which recruit control processes (Botvinick, Braver, Barch, 
Carter, & Cohen, 2001).  Although these data do not speak to the validity of the above 
theories, to our knowledge, there is no evidence in the literature to support patients with 
schizophrenia showing heightened error or conflict detection.  To the contrary, the 
amplitude of ERP components thought to index error or conflict monitoring are generally 
found to be decreased in patients with schizophrenia (Alain, McNeely, He, Christensen, 
& West, 2002; Kopp & Rist, 1999; Mathalon et al., 2002; Weisbrod, Kiefer, Marzinzik, & 
Spitzer, 2000). 
 Another possible interpretation is that these increased trial-by-trial RT 
adjustments based on the immediately preceding trial in schizophrenia could be due to 
a working memory deficit.  Previous studies have shown that as the proportion of stop 
signal trials is increased, mean RT on no-stop signal trials also increases (Logan & 
Burkell, 1986).  Moreover, Emeric, et al. (2007) noted that nonhuman primates and 
humans were sensitive not only to the immediately preceding trial, but as the number of 
preceding consecutive no-stop signal trials increased, no-stop signal RT decreased.  
Likewise, as the number of preceding stop signal trials increased, stop signal RT 
increased.  It is possible that patients with schizophrenia might be basing their 
estimated probability of a stop signal on the upcoming trial on a smaller number of 
preceding trials.  Thus, their estimated probability of a stop signal trial might be more 
biased by the immediately preceding trial than healthy controls, causing a transient 
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increase in RT.  Although there has been little work investigating probability estimation 
in patients with schizophrenia, recent work has suggested a link between working 
memory capacity and accurate estimation of the likelihood of an event, such that 
increased working memory capacity allows a greater number of alternative events to be 
considered and a more accurate probability judgment (Dougherty & Hunter, 2003; 
Dougherty & Hunter, 2003).  There is robust evidence for a fundamental working 
memory impairment in schizophrenia (for meta-analysis see Lee & Park, 2005). 
 
Symptom correlations 
 In the present sample, severity of positive symptoms was negatively correlated 
with the amount of slowing following a noncancelled stop signal trial.  Thus, greater RT 
adjustments following an erroneous noncancelled trial was associated with decreased 
positive symptoms.  Interestingly, patients low on positive symptoms showed relatively 
robust post-error slowing, which is unusual in this task.  The amount of post-error 
slowing in patients high in positive symptoms was closer to the mean in healthy controls 
(Figure 7).  The association of post-error slowing with positive symptoms is a potential 
explanation for mixed results among studies of behavioral indices of performance 
monitoring in schizophrenia, like error awareness and post-error slowing.  Symptom 
profiles of patient samples could lead to differing results across studies.  Moreover, this 
relationship might indicate that increased awareness and subsequent adjustments of 
behavior in schizophrenia might be a compensatory strategy for managing positive 
symptoms and, although highly speculative at this point, a possible avenue for targeted 
behavioral interventions. 
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Limitations 
There are several limitations to the present study, the major limitation being the 
small sample size.  Another potential concern in this study is the use of a tracking 
procedure to dynamically adjust the stop signal delay, and thereby dynamically 
adjusting the difficulty in canceling.  The rationale behind using the tracking procedure 
was to ensure that error rates would be the same across groups and that the bulk of 
trials would be in the dynamic range of the inhibition function.  However, the tracking 
procedure can also lead to transient periods of goal neglect or inattention being related 
to the stop signal delay and trial difficulty.  Future replications of this study will also use 
fixed, random stop signal delays.   
 Another limitation in interpreting the correlation between post-error slowing and 
positive symptoms is the somewhat limited range of positive symptom scores.  Most of 
the participants are relatively high-functioning and their symptoms are fairly well 
managed with neuroleptics.  More subjects with high positive symptoms are needed to 
fully explore the relationship of task performance and response monitoring with 
symptomology.   
   
Summary 
 To conclude, this is the first study investigating response inhibition in patients 
with schizophrenia using an oculomotor version of the stop signal task, and the first 
study in schizophrenia looking at RT adjustments based on trial history in the stop 
signal task.  In our sample, we found no evidence for a slowing of the inhibitory process 
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in schizophrenia, but rather a deficit in triggering this process.  Moreover, this deficit 
existed in spite of increased RT adjustments based on trial history. 
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